Seeking Alpha

Bayer AG (BAYRY.PK +3%) moves higher after announcing its partner Janssen Research &...

Bayer AG (BAYRY.PK +3%) moves higher after announcing its partner Janssen Research & Development has submitted a supplemental new drug application to the FDA for its oral anticoagulant Xarelto, also known as rivaroxaban, in combination with standard antiplatelet therapy to reduce the risk of cardiovascular events in patients with acute coronary syndrome.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs